Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

MCLEAN, Va.--(BUSINESS WIRE)--AIRO Group Holdings, Inc. (Nasdaq: AIRO) (“AIRO” or the “Company”), a global leader in advanced aerospace and defense technologies, today announced that it will host a conference call to report its financial results for the fourth quarter 2025 at 8:00 a.m., ET, on Tuesday, March 31, 2026. Participants can join the call by dialing 1 (800)-715-9871 (US) or 1 (646)-307-1963 (international) and enter the access code 7911023. To listen to the live audio webcast and Q&am...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks will host its highly anticipated annual user conference, Extreme Connect, in Orlando, Florida, May 4–7....

NEW YORK--(BUSINESS WIRE)--The Wagner College Holocaust Center Advisory Board will honor Jane V. DeFazio, Ph.D., Associate Professor, and Mark R. DeFazio with the Monroe J. Klein ’66 Humanitarian Award at the 2026 Community Mitzvah Awards Dinner, recognizing their longstanding commitment to compassion, community service, and support of educational and humanitarian initiatives. The awards dinner will take place Wednesday, March 18, 2026, from 6:00 PM to 10:00 PM at Wagner College’s Union Dining...

BOSTON--(BUSINESS WIRE)--AcuityMD, the intelligence platform for MedTech, announced data revealing increased access to colorectal screening and early treatment at ambulatory surgery centers (ASCs). Across the U.S., the majority of all endoscopic colorectal procedures are now performed in ASCs, lowering barriers to care for patients who might delay or avoid screening. ASCs handled nearly 9 million endoscopic colorectal procedures in 2024 alone, a 50% volume increase since 2018. Endoscopic exams...

PITTSBURGH--(BUSINESS WIRE)--Peptilogics, a surgical therapeutics company dedicated to curing and preventing devastating medical device-related infections (MDRI), has announced the enrollment of the first patient in the RETAIN Phase 2/3 registration trial by Dr. Toan Le at the University of Cincinnati Medical Center. The trial is evaluating PLG0206, a first-in-class anti-biofilm drug candidate, in patients with prosthetic joint infection (PJI), the first of multiple potential MDRI indications....

SAN FRANCISCO--(BUSINESS WIRE)--Kwanti, a leading portfolio analytics solution aiding financial advisors and investment managers with prospect conversion, client retention, model management, proposal generation, and more, today announced multiple new features to its award-winning portfolio analytics platform that bring significant capabilities to how advisors model cash flow and monitor portfolios. KWANTI LAUNCHES NEW CASH FLOW SCENARIOS FEATURE Kwanti’s new Cash Flow Scenarios feature enables...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced presentation of new preclinical study data supporting the potential long-term efficacy of PBGENE-DMD. The data presentation took place during a poster session at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2026 curre...